Global Implantable Brain-Computer Interface Market Size and Forecasts 2030
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

Global Implantable Brain-Computer Interface Market Size and Forecasts 2030

Last Updated:  Apr 26, 2025 | Study Period:

IMPLANTABLE BRAIN-COMPUTER INTERFACE MARKET

 

INTRODUCTION

 A transmitter implanted subcutaneously below the clavicle connects to subdural surface electrodes placed over the motor cortex of the dominant hand as part of the brain-computer interface, allowing continuous readout of electrocorticographic activity.

 

Using brain impulses, a human can operate an external device through a brain-computer interface (BCI). BCIs have a variety of applications, including helping the disabled and enhancing military capabilities.

 

 Brain-machine interfaces (BMIs) and brain computer interfaces (BCIs) are terms for neuro technologies that track brain activity and interpret it to glean usable information.

 

Many BCIs aim to replace or restore Central Nervous System (CNS) functions lost due to illness or accident. Medical applications have received the majority of BCI integrations and research. Other BCIs have more specific objectives.

 

IMPLANTABLE BRAIN-COMPUTER INTERFACE MARKET SIZE AND FORECAST

 

 Implantable Brain-Computer Interface Market Size

 

 The global Implantable brain-computer interface market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 

IMPLANTABLE BRAIN-COMPUTER INTERFACE MARKETNEW PRODUCT LAUNCH

(BUSINESS WIRE) NEW YORK The first human BCI implant in the United States has been announced by Synchron, a business that specialises in endovascular brain-computer interfaces (BCI). This method, which is the first to use an endovascular BCI approach and does not necessitate invasive open-brain surgery, marks a key technological milestone for scalable BCI devices.

 

In Synchron's COMMAND trial, which is being carried out under the first experimental device exemption (IDE) granted by the FDA to a company evaluating a permanently implanted BCI, the technique represents the first U.S. patient implant.

 

Clinical investigator, assistant professor of neurosurgery, neurology, and radiology at the Icahn School of Medicine at Mount Sinai, oversaw the procedure at Mount Sinai West in New York. The procedure was carried out using a minimally invasive, endovascular technique in the angiography suite.The surgery was coordinated with assistance from Mount Sinai's Department of Rehabilitation and Human Performance.

 

According to MD, the neurointerventional surgeon who carried out the treatment and an assistant professor of neurosurgery, neurology, and radiology at the Icahn School of Medicine at Mount Sinai, "That is a tremendously exciting milestone for the discipline because of its ramifications and huge potential."

 

The implantation technique went quite well, and 48 hours after the operation, the patient was ready to return home.

 

An powerful implanted brain-computer interface (BCI) device called KernelFlow was created by the well-known neurotechnology firm Kernel. KernelFlow is an important advancement in the field of neuroprosthetics, designed to improve cognitive capacities and extend our understanding of the human brain.

 

A small implanted device that provides direct connection with the brain is the heart of the KernelFlow technology. This implant can record and stimulate brain activity with outstanding accuracy and resolution since it is comprised of biocompatible materials.

 

To guarantee long-term compatibility and safety within the body, its implantation is carried out with the highest care. KernelFlow's superior brain recording capabilities are what set it apart from competing systems. The implant has a number of tiny electrodes that can pick up and store electrical impulses coming from specific neurons.

 

Researchers and physicians may better comprehend cognitive processes and neurological problems with the use of this capacity to record neural activity, which offers insightful information about how the brain functions. The high-density electrode array makes it possible to scan and analyze the patterns of brain activity in great detail.

 

Innovative stimulation possibilities are also available with KernelFlow. The technology can alter neural activity and perhaps relieve symptoms related to neurological diseases by sending precise electrical pulses to selected parts of the brain.

 

This function is important for examining how particular brain regions affect cognitive processes and looking at potential therapeutic approaches. The Brain Interface Unit (BIU), an external device that serves as a communication hub, and the implant function in concert.

 

In order to communicate data and regulate the implant, the BIU establishes a wireless connection with it. It functions as an interface for scientists and medical professionals to communicate with the implant, set stimulation parameters, and review recorded brain data.

 

Furthermore, the implant is wirelessly charged by the BIU, enabling ongoing functioning without the need for regular battery changes. With the aim of enhancing KernelFlow, Kernel offers a full software package that can be easily integrated into research and clinical contexts.

 

This set of tools for data analysis, visualization, and machine learning is quite potent. These techniques can be used by researchers to glean important insights from the enormous quantity of neurological data the implant has gathered.

 

The implant may also be monitored and controlled in real-time, enabling adaptive and custom brain stimulation programs. KernelFlow has the potential to change a wide range of industries, including brain-computer interfaces, cognitive improvement, and neuroprosthetics.

 

The device offers up new perspectives for comprehending the intricacies of the human mind by offering an accurate and dependable platform for brain-computer interface.

 

Researchers can look into the brain systems that underlie cognitive functions, create novel treatments for neurological diseases, and consider cutting-edge methods for improving human cognition.

 

A leading company in the field of implanted brain-computer interfaces (BCIs), Cortera Neurotechnologies, provides a cutting-edge device known as the "NeuroLink." In order to provide seamless connection between the human brain and outside equipment, NeuroLink represents a substantial leap in neural interface technology.

 

Cortera Neurotechnologies' NeuroLink technology is intended to improve the capacities of people with neurological conditions or limitations.To enable bidirectional communication with the brain, it is made up of a very sophisticated implanted device and auxiliary external components that function in concert.

 

 

 

IMPLANTABLE BRAIN-COMPUTER INTERFACE MARKETCOMPANY PROFILE

 

IMPLANTABLE BRAIN-COMPUTER INTERFACE MARKETTHIS REPORT WILL ANSWER FOLLOWING QUESTIONS

  1. How many Implantable brain-computer interface are manufactured per annum globally? Who are the sub-component suppliers in different regions?
  2. Cost breakup of a Global Implantable brain-computer interface and key vendor selection criteria
  3. Where is the Implantable brain-computer interface manufactured? What is the average margin per unit?
  4. Market share of Global Implantable brain-computer interface market manufacturers and their upcoming products
  5. Cost advantage for OEMs who manufacture Global Implantable brain-computer interface in-house
  6. key predictions for next 5 years in Global Implantable brain-computer interface market
  7. Average B-2-B Implantable brain-computer interface market price in all segments
  8. Latest trends in Implantable brain-computer interface market, by every market segment
  9. The market size (both volume and value) of the Implantable brain-computer interface market in 2024-2030 and every year in between?
  10. Production breakup of Implantable brain-computer interface market, by suppliers and their OEM relationship

 

Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
18Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
19Market Segmentation, Dynamics and Forecast by Application, 2024-2030
20Market Segmentation, Dynamics and Forecast by End use, 2024-2030
21Product installation rate by OEM, 2023
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2023
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix